KCT0000269已完成未知
A randomized study, Single-Blind, 3-arm, Parallel-Group Study to Compare the Effectiveness of between the selection of distant points and nearby points and only nearby points in Korean patients with temporomandibualr disorders
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 18(Year) 至 71(Year)（—）
- 性别
- All
入选标准
- •Eligible participants were fully from 18 year to 71 year-old, both genders who had no other disease except TMD, complaining of TM-related pain at one side or both sides irrelevant to disease interval, Positive Axis I Group I diagnosis on the Research Diagnostic Criteria (RDC) for temporomandibular disorders, and may have no contraindications to TMD acupuncture treatment.
排除标准
- •Participants were excluded if they had previous surgery for treatment of TMD pain, history of rheumatoid disease or degenerative arthritis, extensive anatomical destruction or deterioration of the TM joint, and diagnosed as having pain of neuropathic or odontogenic origin, had a plan to pregnant in the next 3 months, and whose TMD were caused by non mechanical or spiritual factors. Finally if they had less than 4 points at both TM function score scale and VAS (visual analogue scale) they were excluded.
研究者
相似试验
已完成
不适用
Parallel Two-Arm, Triple-Blind, Randomized Study, whose purpose is to evaluate the efficacy, tolerability and safety of the Dosage of 50 mg of Losartan titled at 50 mg of Losartan / 12.5 mg of Hydrochlorothiazide, titrated to 100 mg of Losartan / 25 mg of Hydrochlorothiazide versus the dose of 5 mg of Amlodipine titrated to 10 mg of Amlodipine, titrated to 10 mg of Amlodipine plus 25 mg of Hydrochlorothiazide in patients suffering from Isolated Systolic Hypertension.Essential (primary) hypertensionI10-I10 Essential (primary) hypertensionPER-040-00MERCK SHARP & DOHME PERU S.R.L.,
进行中（未招募）
1 期
Parallel group, blinded, multi-centre study of mifepristone in patients with endometriosisendometriosis in reproductive-ageMedDRA version: 20.0 Level: PT Classification code 10014778 Term: Endometriosis System Organ Class: 10038604 - Reproductive system and breast disordersEUCTR2018-002367-26-HUitaphar Laboratorios490
进行中（未招募）
1 期
Parallel group, blinded, multi-centre study of mifepristone in patients with endometriosisendometriosis in reproductive-ageMedDRA version: 20.0Level: PTClassification code 10014778Term: EndometriosisSystem Organ Class: 10038604 - Reproductive system and breast disordersEUCTR2018-002367-26-BGitaphar Laboratorios220
进行中（未招募）
1 期
Parallel group, blinded, multi-centre study of mifepristone in patients with endometriosisEUCTR2018-002367-26-PLitaphar Laboratorios490
已完成
不适用
A single center, randomized, double-blind, 3-arm parallel Phase I study to assess pharmacokinetics, safety and tolerability of MYL-1402O solution for intravenous infusion after 90 minute intravenous infusion at one dose level (equivalent weight-adjusted dose (1 mg/kg) compared to the EU and US marketed drug product (Avastin®) in healthy male volunteers.10035227CancerNL-OMON42579Mylan Pharmaceuticals111